| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-2748-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-33047-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-08988-0.025mg | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Alexa Fluor Plus 488 | NBP2-44236AFP488 | |||
| Alexa Fluor Plus 555 | NBP2-44236AFP555 | |||
| Alexa Fluor Plus 594 | NBP2-44236AFP594 | |||
| Alexa Fluor Plus 647 | NBP2-44236AFP647 | |||
| Alexa Fluor Plus 680 | NBP2-44236AFP680 | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Biotin | NBP1-96864 | |||
| FITC | NBP1-96894 | |||
| HRP | NBP1-96865 | |||
| Rhodamine | NBP1-96895 | |||
| Texas Red | NBP1-96875 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26202-50ul | |||
![ELISA: IL-6 Antibody (MQ2-13A5) [NBP2-33047] - Standard curve generated with Rat Anti-Human IL-6-UNLB ( Clone MQ2-13A5) and Rat Anti-Human IL-6-BIOT (Clone MQ2-39C3) followed by Streptavidin-HRP.](http://images.novusbio.com/fullsize/IL-6-Antibody-MQ2-13A5-Flow-Cytometry-NBP2-33047-img0001.jpg "ELISA: IL-6 Antibody (MQ2-13A5) [NBP2-33047] - Standard curve generated with Rat Anti-Human IL-6-UNLB ( Clone MQ2-13A5) and Rat Anti-Human IL-6-BIOT (Clone MQ2-39C3) followed by Streptavidin-HRP.")
![SDS-Page: Porcine IgG Isotype Control [NBP1-97054] - SDS PAGE of Swine IgG Whole Molecule. Lane 1: Reduced Swine IgG Whole Molecule. Lane 2: 5 uL Opal Prestained Marker. Lane 3: Non-Reduced Swine IgG Whole Molecule. Load: 1 ug per lane.](http://images.novusbio.com/fullsize/Porcine IgG Isotype Control-SDS-Page-NBP1-97054-img0002.jpg "SDS-Page: Porcine IgG Isotype Control [NBP1-97054] - SDS PAGE of Swine IgG Whole Molecule. Lane 1: Reduced Swine IgG Whole Molecule. Lane 2: 5 uL Opal Prestained Marker. Lane 3: Non-Reduced Swine IgG Whole Molecule. Load: 1 ug per lane.")
![Flow Cytometry: IL-1 RI Antibody (10E2) [NBP3-26202] - Overlay Peak curve showing NIH/3T3 cells stained with IL-1 RI Antibody (10E2) (red line) at 1:50. Then 10% normal goat serum was Incubated to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45 min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-Mouse IgG (H+L) at 1/200 dilution for 35 min at 4C. Isotype control antibody (green line) was mouse IgG1 (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10, 000 events was performed.](http://images.novusbio.com/fullsize/nbp3-26202_mouse-il-1-ri-mab-10e2-282202414183612.jpg "Flow Cytometry: IL-1 RI Antibody (10E2) [NBP3-26202] - Overlay Peak curve showing NIH/3T3 cells stained with IL-1 RI Antibody (10E2) (red line) at 1:50. Then 10% normal goat serum was Incubated to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45 min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-Mouse IgG (H+L) at 1/200 dilution for 35 min at 4C. Isotype control antibody (green line) was mouse IgG1 (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10, 000 events was performed.")
![Flow Cytometry: CD4 Antibody (GC1A) [NBP2-60890] - Obtained with caprine leukocytes](http://images.novusbio.com/fullsize/CD4-Antibody-GC1A-Flow-Cytometry-NBP2-60890-img0001.jpg "Flow Cytometry: CD4 Antibody (GC1A) [NBP2-60890] - Obtained with caprine leukocytes")
![Neutralization: IL-21 Antibody (MT216G/21.3m) [NBP3-18290] - The neutralizing capacity and ND50 was determined using ELISA andELISpot. A) HEK cells were transfected to express the IL-21 activation pathway with alkaline phosphatase as a reporter. Cells were stimulated in the presence of recombinant human IL-21 (10 ng/ml) with or without serial dilutions of NBP3-18290. After overnight incubation, enzyme activity was measured in ELISA. B) Human peripheral blood mononuclear cells (PBMC) were incubated with recombinant IL-21 (10 ng/ml) with or without serial dilutions of NBP3-18290. After 4 days the IgG-secreting B cells were quantified by ELISpot.](http://images.novusbio.com/fullsize/IL-21-Antibody-MT216G-21-3m-Neutralization-NBP3-18290-img0001.jpg "Neutralization: IL-21 Antibody (MT216G/21.3m) [NBP3-18290] - The neutralizing capacity and ND50 was determined using ELISA andELISpot. A) HEK cells were transfected to express the IL-21 activation pathway with alkaline phosphatase as a reporter. Cells were stimulated in the presence of recombinant human IL-21 (10 ng/ml) with or without serial dilutions of NBP3-18290. After overnight incubation, enzyme activity was measured in ELISA. B) Human peripheral blood mononuclear cells (PBMC) were incubated with recombinant IL-21 (10 ng/ml) with or without serial dilutions of NBP3-18290. After 4 days the IgG-secreting B cells were quantified by ELISpot.")